Biomarker for diagnosis of rejection after heart transplantation;Biomarker zur Diagnose der zellulären Abstoßung nach Herztransplantation

Herz

Volumn 35, Issue 1, 2010, Pages 11-16

  Frick, Matthias ^a   Antretter, Herwig ^a   Pachinger, Otmar ^a   Pölzl, Gerhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Biomarker; Heart transplantation; Rejection

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ACUTE GRAFT REJECTION; CARDIAC GRAFT REJECTION; ELECTROCARDIOGRAM; GENE EXPRESSION; GOLD STANDARD; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

BIOLOGICAL MARKERS; BIOPSY; ENDOCARDIUM; GENE EXPRESSION PROFILING; GENETIC MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLAMMATION MEDIATORS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TROPONIN;

EID: 76749152333     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-010-3309-3     Document Type: Review

References (55)

1. P.K. Caves E.B. Stinson M. Billingham 1973 Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique Ann Thorac Surg 16 325 36 1:STN:280:DyaE2c%2Fhtlyqsw%3D%3D 4583546
2. R.C. Robbins C.W. Barlow P.E. Oyer 1999 Thirty years of cardiac transplantation at Stanford university J Thorac Cardiovasc Surg 117 939 51 10.1016/S0022-5223(99)70375-2 1:STN:280:DyaK1M3jvVOlsw%3D%3D 10220689 (Pubitemid 29210778)
3. H.J. Eisen E.M. Tuzcu R. Dorent 2003 Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 847 58 10.1056/NEJMoa022171 1:CAS:528:DC%2BD3sXmvVSntrc%3D 12944570 (Pubitemid 37025404)
4. J.A. Kobashigawa L.W. Miller S.D. Russell 2006 Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report Am J Transplant 6 1377 86 10.1111/j.1600-6143.2006.01290.x 1:CAS:528:DC%2BD28XlvVyhtb4%3D 16686761 (Pubitemid 44030320)
5. C.C. Marboe M. Billingham H. Eisen 2005 Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT grade 2 and 3A rejection in cardiac allograft recipients J Heart Lung Transplant 24 S219 26 10.1016/j.healun.2005.04.001 15993777 (Pubitemid 40922653)
6. G.L. Winters B.M. McManus 1996 Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists J Heart Lung Transplant 15 728 35 1:STN:280:DyaK28vhvVSjtw%3D%3D 8820790
7. S. Mondillo M. Maccherini M. Galderisi 2008 Usefulness and limitations of transthoracic echocardiography in heart transplantation recipients Cardiovasc Ultrasound 6 2 13 10.1186/1476-7120-6-2 18190712 (Pubitemid 351302478)
8. C.R. Butler R. Thompson M. Haykowsky 2009 Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review J Cardiovasc Magn Reson 11 7 18 10.1186/1532-429X-11-7 19284612
9. T. Auer G. Schreier H. Hutten 1995 Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats Transplant Proc 27 2621 4 1:STN:280:DyaK28%2FkvFemsA%3D%3D 7482856
10. R. Bourge H. Eisen R. Hershberger 1998 Noninvasive rejection monitoring of cardiac transplants using high resolution intramyocardial electrograms: initial US multicenter experience Pacing Clin Electrophysiol 21 2338 44 10.1111/j.1540-8159.1998.tb01178.x 1:STN:280:DyaK1M%2Fkt1Ortw%3D%3D 9825344
11. J. Mair A. Hammerer-Lercher B. Puschendorf 2001 The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure Clin Chem Lab Med 39 571 88 10.1515/CCLM.2001.093 1:CAS:528: DC%2BD3MXmslSmsr8%3D 11522102 (Pubitemid 32725741)
12. C.E. Angermann G. Ertl 2004 Natriuretic peptides - new diagnostic markers in heart disease Herz 29 609 17 10.1007/s00059-004-2619-8 15912436 (Pubitemid 39366051)
13. D.S. Ang C.F. Kong M.P. Kao 2009 Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities Am Heart J 158 133 40 10.1016/j.ahj.2009.04.024 1:CAS:528:DC%2BD1MXnsFSis7w%3D 19540403
14. A. El Gamel N.A. Yonan B. Keevil 1997 Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation Ann Thorac Surg 63 1095 100 10.1016/S0003-4975(97)00168-9 1:STN:280:DyaK2s3kvVehtA%3D%3D 9124912 (Pubitemid 27191668)
15. A. Ationu M. Burch D. Singer 1993 Cardiac transplantation affects ventricular expression of brain natriuretic peptide Cardiovasc Res 27 188 91 10.1093/cvr/27.2.188 1:CAS:528:DyaK3sXmsVOjsb4%3D 8472270
16. M.G. Buckley M.H. Yacoub D.R. Singer 1998 Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients J Hum Hypertens 12 825 6 10.1038/sj.jhh.1000606 1:CAS:528:DyaK1MXhslSqtQ%3D%3D 9883703
17. I.P. Garrido D.A. Pascual-Figal F. Nicolás 2009 Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation Am J Cardiol 103 1149 53 10.1016/j.amjcard.2009.01.008 1:CAS:528:DC%2BD1MXktl2jtr8%3D 19361605
18. T. Ogawa J.P. Veinot R.A. Davies 2005 Neuroendocrine profiling of humans receiving cardiac allografts J Heart Lung Transplant 24 1046 54 10.1016/j.healun.2004.06.023 16102440 (Pubitemid 41127187)
19. W.C. Kirchhoff R. Gradaus J. Stypmann 2004 Vasoactive peptides during long-term follow-up of patients after cardiac transplantation J Heart Lung Transplant 23 284 8 10.1016/S1053-2498(03)00190-6 15019637 (Pubitemid 38333085)
20. Y.T. Lan R.K. Chang J.C. Alejos 2004 B-type natriuretic peptide in children after cardiac transplantation J Heart Lung Transplant 23 558 63 10.1016/S1053-2498(03)00306-1 15135371 (Pubitemid 38595740)
21. M.A. Arnau-Vives L. Almenar I. Hervas 2004 Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection J Heart Lung Transplant 23 850 6 10.1016/j.healun.2003.08.005 15261180 (Pubitemid 38953868)
22. A.H. Wu M.L. Johnson K.D. Aaronson 2005 Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements J Heart Lung Transplant 24 52 7 10.1016/j.healun.2003.10.012 15653379 (Pubitemid 40093992)
23. A. Hammerer-Lercher J. Mair H. Antretter 2005 B-type natriuretic peptide as a marker of allograft rejection after heart transplantation J Heart Lung Transplant 24 1444 8 16143273
24. J.O. O'Neill A.T. McRae 3rd R.W. Troughton 2005 Brain natriuretic peptide levels do not correlate with acute cellular rejection in de novo orthotopic heart transplant recipients J Heart Lung Transplant 24 416 20 10.1016/j.healun.2003.12.006 15797742 (Pubitemid 40403797)
25. M.R. Mehra P.A. Uber S. Potluri 2004 Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation Am J Cardiol 94 454 8 10.1016/j.amjcard.2004.04.060 1:CAS:528:DC%2BD2cXmvFCqsL0%3D 15325928 (Pubitemid 39119994)
26. L. Martinez-Dolz L. Almenar J. Moro 2007 Prognostic value of brain natriuretic peptide in heart transplant patients J Heart Lung Transplant 26 986 91 10.1016/j.healun.2007.07.023 1:STN:280:DC%2BD2srpvFCiuw%3D%3D 17919617 (Pubitemid 47494656)
27. L. Martínez-Dolz L. Almenar I. Hervás 2008 Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation J Heart Lung Transplant 27 735 40 10.1016/j.healun.2008.04.008 18582802
28. R. Zimmermann S. Baki T.J. Dengler 1993 Troponin T release after heart transplantation Br Heart J 69 395 8 10.1136/hrt.69.5.395 1:STN:280: DyaK3s3pvVCrsg%3D%3D 8518061
29. M. Hossein-Nia J. Mascaro W.J. McKenna 1993 Troponin T as a non-invasive marker of cardiac allograft rejection Lancet 341 838 10.1016/0140-6736(93)90621- M 1:STN:280:DyaK3s3gsVKitA%3D%3D 8096046
30. T.J. Dengler R. Zimmermann K. Braun 1998 Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation J Am Coll Cardiol 32 405 12 10.1016/S0735-1097(98)00257-5 1:CAS:528:DyaK1cXlsF2rtL8%3D 9708468 (Pubitemid 28396490)
31. J.J. Chance J.B. Segal G. Wallerson 2001 Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejection Clin Chim Acta 312 31 9 10.1016/S0009-8981(01)00590-3 1:CAS:528:DC%2BD3MXnt1Whsrg%3D 11580907 (Pubitemid 32913578)
32. C.W. Wang S.R. Steinhubl W.J. Castellani 1996 Inability of serum myocyte death markers to predict acute cardiac allograft rejection Transplantation 62 1938 41 10.1097/00007890-199612270-00046 1:STN:280:DyaK2s7ksVKhtw%3D%3D 8990392 (Pubitemid 27014567)
33. J.D. Alexis C.D. Lao J.G. Selter 1998 Cardiac troponin T: a noninvasive marker for heart transplant rejection? J Heart Lung Transplant 17 395 8 1:STN:280:DyaK1c3ksl2qug%3D%3D 9588584
34. J.C. Mullen M.J. Bentley K.D. Scherr 2002 Troponin T and I are not reliable markers of cardiac transplant rejection Eur J Cardiothorac Surg 22 233 7 10.1016/S1010-7940(02)00293-2 1:STN:280:DC%2BD38zptlygsg%3D%3D 12142191 (Pubitemid 34831862)
35. M.E. Billingham N.R. Cary M.E. Hammond 1990 A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation J Heart Transplant 9 587 93 1:STN:280:DyaK3M7hs1Cjtg%3D%3D 2277293
36. S. Stewart G.L. Winters M.C. Fishbein 2005 Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 1710 20 10.1016/j.healun.2005.03.019 16297770 (Pubitemid 41641841)
37. C.A. Labarrere D.R. Nelson C.J. Cox 2000 Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation JAMA 284 457 64 10.1001/jama.284.4.457 1:CAS:528: DC%2BD3cXlvVSlsbw%3D 10904509
38. P.M. Ridker P. Haughie 1998 Prospective studies of C-reactive protein as a risk factor for cardiovascular disease J Invest Med 46 391 5 1:STN:280:DyaK1M%2Fit1altQ%3D%3D
39. P.M. Ridker M. Cushman M.J. Stampfer 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 973 9 10.1056/NEJM199704033361401 1:CAS:528:DyaK2sXisFOrtL0%3D 9077376 (Pubitemid 27152782)
40. G. Liuzzo L.M. Biasucci J.R. Gallimore 1994 The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 417 4 10.1056/NEJM199408183310701 1:STN:280:DyaK2czgvFKruw%3D%3D 7880233 (Pubitemid 24247397)
41. Harkiss GD. Serial study of C reactive protein concentrations in cardiac allograft recipients. J Clin Pathol 1985;38:193-7.
42. R.M. Sánchez-Soriano L. Almenar L. Martínez-Dolz 2006 Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation Transplant Proc 38 2569 71 10.1016/j.transproceed.2006.09. 002 17098005 (Pubitemid 44693745)
43. Martínez-Dolz L, Almenar L, Reganon E, et al. What is the best biomarker for diagnosis of rejection in heart transplantation? Clin Transplant 2009;23:672-80.
44. T. Van Gelder A.H. Balk P.E. Zondervan 1998 C-reactive protein in the monitoring of acute rejection after heart transplantation Transpl Int 11 361 4 10.1111/j.1432-2277.1998.tb00818.x 9787412
45. A. Balduini C. Campana M. Ceresa 2003 Utility of biochemical markers in the follow-up of heart transplant recipients Transplant Proc 35 3075 8 10.1016/j.transproceed.2003.10.044 1:CAS:528:DC%2BD3sXhtVSjsr7E 14697983 (Pubitemid 38102135)
46. M. Assicot D. Gendrel H. Carsin 1993 High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 515 8 10.1016/0140-6736(93)90277-N 1:STN:280:DyaK3s7nt1yjuw%3D%3D 8094770 (Pubitemid 23066085)
47. M.W. Nijsten P. Olinga T.H. The 2000 Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro Crit Care Med 28 458 61 10.1097/00003246-200002000-00028 1:STN:280:DC%2BD3c7ntVCmtA%3D%3D 10708183
48. S. Hammer P. Fraunberger B. Meiser 1999 Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients Ann Transplant 4 5 9 1:CAS:528:DC%2BD3cXnsF2mur0%3D 10850584
49. U. Boeken P. Feindt M. Micek 2000 Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX) Cardiovasc Surg 8 550 4 10.1016/S0967-2109(00) 00070-3 1:STN:280:DC%2BD3M%2FmtF2nsQ%3D%3D 11068216 (Pubitemid 30793285)
50. S. Hammer F. Meisner P. Dirschedl 2000 Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts Intensive Care Med 26 2 S182 6 10.1007/BF02900735 18470717
51. M.S. Eisenberg H.J. Chen M.K. Warshofsky 2000 Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients Circulation 102 2100 4 1:CAS:528:DC%2BD3cXotVCqtLc%3D 11044427
52. M. Schena D. Shalon R.W. Davis 1995 Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 467 70 10.1126/science.270.5235.467 1:CAS:528:DyaK2MXovVersLk%3D 7569999
53. A.S. Jun S.H. Liu E.H. Koo 2001 Microarray analysis of gene expression in human donor corneas Arch Ophthalmol 119 1629 34 1:CAS:528:DC%2BD3MXptVOkurY%3D 11709013
54. M.C. Deng H.J. Eisen M.R. Mehra 2006 Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling Am J Transplant 6 150 60 10.1111/j.1600-6143.2005.01175.x 1:CAS:528: DC%2BD28Xpt1Kjsg%3D%3D 16433769 (Pubitemid 43382213)
55. M.R. Mehra J.A. Kobashigawa M.C. Deng 2008 Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection J Heart Lung Transplant 27 297 301 10.1016/j.healun.2007.11.578 18342752